Skip to main
CCRN
CCRN logo

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 8%
Hold 67%
Sell 8%
Strong Sell 0%

Bulls say

Cross Country Healthcare is experiencing a positive outlook due to a projected inflection point in its largest segment, travel nurse staffing, driven by improving market demand and recent managed service provider contract wins. In Q4/24, the company achieved revenue of $309.9 million, reflecting strong performance in its non-travel segments and aligning with the high end of guidance, contributing to a total revenue of slightly more than $2.0 billion for 2023. Additionally, the acquisition agreement by Aya Healthcare for $18.61 per share, representing a 67% premium, underscores the market's confidence in Cross Country's ongoing value and growth potential.

Bears say

Cross Country Healthcare experienced a significant revenue decline of 25% year-over-year, attributed to continued softer demand conditions in the healthcare travel staffing industry. The company reported a substantial drop in adjusted EBITDA, down 55% year-over-year to $9.3 million, with ongoing pressure on gross margins due to competitive pricing and reduced demand for contingent labor. Additionally, the company's 2025 estimates have been notably lowered, with projected revenue decreased to $1.255 billion and adjusted EBITDA estimates scaled back to $39.2 million, reflecting a conservative outlook on the recovery in the travel staffing sector.

CCRN has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 8% recommend Buy, 67% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 12 analysts, CCRN has a Hold consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.23, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.23, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.